Not applicableStudy completedNCT01414595What this trial is testingStudy of Tissue Samples From Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 248
Testing effectiveness (Phase 2)Looking for participantsNCT03556228What this trial is testingVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaWho this might be right forHead and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more VM Oncology, LLC 242
Large-scale testing (Phase 3)Study completedNCT03875092What this trial is testingCarboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension StudyWho this might be right forNon-small Cell Lung Cancer Merck Sharp & Dohme LLC 125
Testing effectiveness (Phase 2)Looking for participantsNCT07489066What this trial is testingSymbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCWho this might be right forCarcinomaNon-Small-Cell LungLung Cancer (NSCLC)+6 more Pfizer 120
Testing effectiveness (Phase 2)Study completedNCT00960999What this trial is testingRadiation Therapy in Treating Patients With Stage I Non-Small Cell Lung CancerWho this might be right forLung Cancer Radiation Therapy Oncology Group 94
Early research (Phase 1)Study completedNCT06307093What this trial is testingStudy Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant NeoplasmsWho this might be right forSkin MelanomaSquamous Non-small-cell Lung CancerHead and Neck Squamous Cell Carcinoma R-Pharm 90
Testing effectiveness (Phase 2)Study completedNCT01204307What this trial is testingInfluence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene MutationWho this might be right forAdvanced Non-Squamous Non-Small Cell Lung Cancer Chang Gung Memorial Hospital 101
Large-scale testing (Phase 3)Active Not RecruitingNCT06939595What this trial is testingCompare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung CancerWho this might be right forNon Squamous Non Small Cell Lung Cancer Celltrion 225
Testing effectiveness (Phase 2)Ended earlyNCT00509366What this trial is testingStudy Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Duke University 101
Large-scale testing (Phase 3)Active Not RecruitingNCT06505837What this trial is testingJS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）Who this might be right forRecurrent Metastatic Non-Squamous Non Small Cell Lung Cancer Shanghai Junshi Bioscience Co., Ltd. 395
Testing effectiveness (Phase 2)Ended earlyNCT00958321What this trial is testingPositron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35Who this might be right forLung CancerMetastatic Cancer Cancer Trials Ireland 40
Testing effectiveness (Phase 2)Looking for participantsNCT05841472What this trial is testingAnti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerWho this might be right forNon Squamous Non Small Cell Lung Cancer CrystalGenomics, Inc. 60
Early research (Phase 1)Active Not RecruitingNCT05783622What this trial is testingStudy of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forNon-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more Janux Therapeutics 130
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Not applicableStudy completedNCT00004138What this trial is testingPositron Emission Tomography for Detecting Non-small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 303
Testing effectiveness (Phase 2)Study completedNCT05077709What this trial is testingIO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBCWho this might be right forLung Cancer Non Small CellHead and Neck Squamous Cell CarcinomaUrothelial Carcinoma Bladder IO Biotech 63
Testing effectiveness (Phase 2)UnknownNCT05900921What this trial is testingTrilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung CancerWho this might be right forAdvanced Squamous Non-Small-Cell Lung Cancer Sichuan University 132
Not applicableStudy completedNCT01488331What this trial is testingAn Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung CancerWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 217
Early research (Phase 1)Looking for participantsNCT05983432What this trial is testingEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsWho this might be right forNon Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more SystImmune Inc. 540
Testing effectiveness (Phase 2)UnknownNCT04396457What this trial is testingPembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901Who this might be right forNon-squamous Non-small-cell Lung CancerCancer, Lung National Hospital Organization Nagoya Medical Center 50